Molecular and genetic basis of neurocognitive alterations in patients with SMI, in order to develop biomarkers, diagnostic assessment tools and therapeutic interventions helping to improve the functional prognosis, the autonomy and the life quality of these people.
Comprehend the unexpected associations between apparently different diseases, like cancer and certain diseases of the central nervous system.
Prevention of fragility signs in populations at risk by assessing human functions (functional and neurocognitive assessment) and by incorporating nutritional medicine studies on Omega 3.
Study of sex differences in the different processes of drug addiction and in the presence and manifestation of dual pathology.
Networking on the burden of disease.
Study of the biological and environmental factors involved in cocaine addiction. Study of different neurotransmitter systems on the reinforcing effects of cocaine. Influence of environmental factors, exposure to stress (physical, social or psychological) or personality.
Search for vulnerability and prevention factors in the development of psychiatric disorders and addiction to substances of abuse.
This line studies the neurobiological and environmental factors involved in the development of MDMA dependence and, especially, in relapse after a period of abstinence.
